Originally published by our sister publication Pain Medicine News.
When it comes to long-term improvements following 60 days of percutaneous peripheral nerve stimulation (PNS; SPRINT system, SPR Therapeutics), a new study has found not only notable improvements in average pain scores, but also demonstrated decreases in consumption of opioids and/or gabapentinoids during the treatment period.
The results from this real-world study—a cross-sectional follow-up of 354 patients with a host of